The settlement in U.S. v. Gilead could disturb the model of public-private partnership that sustains many of the United ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

For decades, scientists across the globe have investigated methods to accurately measure drug permeability across the blood-brain barrier, a compact layer of cells that protect the brain from ...

In this Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, speaks about how distrust and uncertainty ...

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...

Roivant Sciences posted earnings that exceeded expectations, with substantial progress in its diversified drug pipeline.

Following these transactions, the involved parties now hold a total of 6,684,962 shares of Sionna Therapeutics' common stock. This strategic move reflects TPG's continued interest and investment in ...

Daewoong Pharmaceutical achieves record revenue and operating profit in 2022 Daewoong Pharmaceutical sets new performance ...